Back to search

Article

Improved gene targeting in vivo using EoHR, a small molecule inhibitor of 53BP1

2024-06-01

Abstract excerpt

Precise genome editing by programmable nucleases such as Cas9 has revolutionised medical research by enabling the creation of gene-edited or knock-in mouse models of disease. However, a major limitation of the approach is the inefficient process of homology driven recombination (HDR) from an exogenous DNA repair template. This is because error-prone, 53BP1-dependent non-homologous end joining (NHEJ) predominates a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bea19e2f-5eac-51c7-af13-760ab0a5a323
DOI
10.1101/2024.05.30.596757
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Improved gene targeting in vivo using EoHR, a small molecule inhibitor of 53BP1DOI 10.1101/2024.05.30.596757
Select a neighboring publication to make it the new centre.